{
  "drug_name": "Cefuroxime",
  "url": "https://wikem.org/wiki/Cefuroxime",
  "scraped_at": "2026-01-10T07:50:02.209467",
  "sections": {
    "General": {
      "text": "Type: 2nd generation\ncephalosporin\nDosage Forms: tablet, powder for injection\nDosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g\nRoutes of Administration: PO, IV, IM\nCommon Trade Names: Ceftin, Zinacef, Kefurox",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "cephalosporin",
          "url": "https://wikem.org/wiki/Cephalosporin"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Mild-Moderate_Bacterial_infections": {
          "text": "250-500mg PO BID x5-10 days",
          "tables": []
        },
        "Steptococcal_Pharyngitis/Tonsillitis": {
          "text": "250mg PO BID x10 days",
          "tables": []
        },
        "Acute_Maxillary_Sinusitis": {
          "text": "250mg PO BID x10 days; Info: not recommended per IDSA guidelines",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections": {
          "text": "1000mg PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for chlamydial co-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease": {
          "text": "500mg PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Mild-Moderate_Bacterial_infections": {
      "text": "250-500mg PO BID x5-10 days",
      "subsections": {
        "Steptococcal_Pharyngitis/Tonsillitis": {
          "text": "250mg PO BID x10 days",
          "tables": []
        },
        "Acute_Maxillary_Sinusitis": {
          "text": "250mg PO BID x10 days; Info: not recommended per IDSA guidelines",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections": {
          "text": "1000mg PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for chlamydial co-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease": {
          "text": "500mg PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Steptococcal_Pharyngitis/Tonsillitis": {
      "text": "250mg PO BID x10 days",
      "subsections": {
        "Acute_Maxillary_Sinusitis": {
          "text": "250mg PO BID x10 days; Info: not recommended per IDSA guidelines",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections": {
          "text": "1000mg PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for chlamydial co-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease": {
          "text": "500mg PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Acute_Maxillary_Sinusitis": {
      "text": "250mg PO BID x10 days; Info: not recommended per IDSA guidelines",
      "subsections": {
        "Uncomplicated_Gonococcal_Infections": {
          "text": "1000mg PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for chlamydial co-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease": {
          "text": "500mg PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Uncomplicated_Gonococcal_Infections": {
      "text": "1000mg PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for chlamydial co-infection recommended",
      "subsections": {
        "Early_Lyme_Disease": {
          "text": "500mg PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Early_Lyme_Disease": {
      "text": "500mg PO BID x20 days",
      "subsections": {
        "Renal_Dosing": {
          "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "not defined",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Mild-Moderate_Bacterial_Infections_2": {
          "text": "3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food\n>13 yo: Dose: 250-500mg tab PO BID x5-10 days; Info: dose, duration varies by infection type, severity",
          "tables": []
        },
        "Acute_Otitis_Media": {
          "text": "2 mo-5 yo Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food\n6-12 yo: Dose: 30mg/kg/day susp PO divided q12h x5-10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x5-10 days; Info: give susp with food",
          "tables": []
        },
        "Acute_Maxillary_Sinusitis_2": {
          "text": "3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines; give susp with food\n>13 yo: Dose: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines",
          "tables": []
        },
        "Streptococcal_Pharyngitis/Tonsillitis": {
          "text": "3 mo-12 yo: Dose: 20mg/kg/day susp PO divided q12h x10 days; Max: 500mg/day; Info: give with food\n>13 yo: Dose: 250mg tab PO BID x10 days",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections_2": {
          "text": "adolescents: Dose: 1000mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for\nchlamydial\nco-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease_2": {
          "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "chlamydial",
          "url": "https://wikem.org/wiki/Chlamydial"
        }
      ]
    },
    "Mild-Moderate_Bacterial_Infections_2": {
      "text": "3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food\n>13 yo: Dose: 250-500mg tab PO BID x5-10 days; Info: dose, duration varies by infection type, severity",
      "subsections": {
        "Acute_Otitis_Media": {
          "text": "2 mo-5 yo Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food\n6-12 yo: Dose: 30mg/kg/day susp PO divided q12h x5-10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x5-10 days; Info: give susp with food",
          "tables": []
        },
        "Acute_Maxillary_Sinusitis_2": {
          "text": "3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines; give susp with food\n>13 yo: Dose: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines",
          "tables": []
        },
        "Streptococcal_Pharyngitis/Tonsillitis": {
          "text": "3 mo-12 yo: Dose: 20mg/kg/day susp PO divided q12h x10 days; Max: 500mg/day; Info: give with food\n>13 yo: Dose: 250mg tab PO BID x10 days",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections_2": {
          "text": "adolescents: Dose: 1000mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for\nchlamydial\nco-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease_2": {
          "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "chlamydial",
          "url": "https://wikem.org/wiki/Chlamydial"
        }
      ]
    },
    "Acute_Otitis_Media": {
      "text": "2 mo-5 yo Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food\n6-12 yo: Dose: 30mg/kg/day susp PO divided q12h x5-10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x5-10 days; Info: give susp with food",
      "subsections": {
        "Acute_Maxillary_Sinusitis_2": {
          "text": "3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines; give susp with food\n>13 yo: Dose: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines",
          "tables": []
        },
        "Streptococcal_Pharyngitis/Tonsillitis": {
          "text": "3 mo-12 yo: Dose: 20mg/kg/day susp PO divided q12h x10 days; Max: 500mg/day; Info: give with food\n>13 yo: Dose: 250mg tab PO BID x10 days",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections_2": {
          "text": "adolescents: Dose: 1000mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for\nchlamydial\nco-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease_2": {
          "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "chlamydial",
          "url": "https://wikem.org/wiki/Chlamydial"
        }
      ]
    },
    "Acute_Maxillary_Sinusitis_2": {
      "text": "3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines; give susp with food\n>13 yo: Dose: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines",
      "subsections": {
        "Streptococcal_Pharyngitis/Tonsillitis": {
          "text": "3 mo-12 yo: Dose: 20mg/kg/day susp PO divided q12h x10 days; Max: 500mg/day; Info: give with food\n>13 yo: Dose: 250mg tab PO BID x10 days",
          "tables": []
        },
        "Uncomplicated_Gonococcal_Infections_2": {
          "text": "adolescents: Dose: 1000mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for\nchlamydial\nco-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease_2": {
          "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "chlamydial",
          "url": "https://wikem.org/wiki/Chlamydial"
        }
      ]
    },
    "Streptococcal_Pharyngitis/Tonsillitis": {
      "text": "3 mo-12 yo: Dose: 20mg/kg/day susp PO divided q12h x10 days; Max: 500mg/day; Info: give with food\n>13 yo: Dose: 250mg tab PO BID x10 days",
      "subsections": {
        "Uncomplicated_Gonococcal_Infections_2": {
          "text": "adolescents: Dose: 1000mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for\nchlamydial\nco-infection recommended",
          "tables": []
        },
        "Early_Lyme_Disease_2": {
          "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "chlamydial",
          "url": "https://wikem.org/wiki/Chlamydial"
        }
      ]
    },
    "Uncomplicated_Gonococcal_Infections_2": {
      "text": "adolescents: Dose: 1000mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for\nchlamydial\nco-infection recommended",
      "subsections": {
        "Early_Lyme_Disease_2": {
          "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
          "tables": []
        },
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "chlamydial",
          "url": "https://wikem.org/wiki/Chlamydial"
        }
      ]
    },
    "Early_Lyme_Disease_2": {
      "text": ">13 yo: Dose: 500mg tab PO BID x20 days",
      "subsections": {
        "Renal_Dosing_2": {
          "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
          "tables": []
        },
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing_2": {
      "text": "3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement\n>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement",
      "subsections": {
        "Hepatic_Dosing_2": {
          "text": "not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing_2": {
      "text": "not defined",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy: B\nLactation: Probably Safe\nRenal Dosing\nAdult: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement\nPediatric: 3 mo-12 yo: CrCl <10: 15mg/kg susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement; >13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement\nHepatic Dosing\nAdult: Not defined\nPediatric: Not defined",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug (See\nCephalosporin Cross-reactivity\n)\nCaution if hypersensitive to\nPCN\nCaution if renal impairment\nCaution if hepatic impairment\nCaution if seizure disorder\nCaution if malnutrition\nCaution if recent antibiotic-associated colitis history",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Cephalosporin Cross-reactivity",
          "url": "https://wikem.org/wiki/Cephalosporin_Cross-reactivity"
        },
        {
          "text": "PCN",
          "url": "https://wikem.org/wiki/PCN"
        }
      ]
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Anaphylaxis\nAngioedema\nToxic epidermal necrolysis\nStevens-Johnson syndrome\nInterstitial nephritis\nPancytopenia\nThrombocytopenia\nAgranulocytosis\nLeukopenia\nNeutropenia\nHemolytic Anemia\nSeizures\nClostridium difficile\nassociated diarrhea",
          "tables": []
        },
        "Common": {
          "text": "Diarrhea\nNausea/Vomiting\nJarisch-Herxheimer reaction\nVaginitis\nDiaper Rash\nALT, AST elevated\nRenal Impairment\nAnemia",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Angioedema",
          "url": "https://wikem.org/wiki/Angioedema"
        },
        {
          "text": "Toxic epidermal necrolysis",
          "url": "https://wikem.org/wiki/TEN"
        },
        {
          "text": "Stevens-Johnson syndrome",
          "url": "https://wikem.org/wiki/Stevens-Johnson_Syndrome"
        },
        {
          "text": "Thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Seizures",
          "url": "https://wikem.org/wiki/Seizures"
        },
        {
          "text": "Clostridium difficile",
          "url": "https://wikem.org/wiki/Clostridium_difficile"
        },
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        },
        {
          "text": "Vaginitis",
          "url": "https://wikem.org/wiki/Vaginitis"
        }
      ]
    },
    "Serious": {
      "text": "Anaphylaxis\nAngioedema\nToxic epidermal necrolysis\nStevens-Johnson syndrome\nInterstitial nephritis\nPancytopenia\nThrombocytopenia\nAgranulocytosis\nLeukopenia\nNeutropenia\nHemolytic Anemia\nSeizures\nClostridium difficile\nassociated diarrhea",
      "subsections": {
        "Common": {
          "text": "Diarrhea\nNausea/Vomiting\nJarisch-Herxheimer reaction\nVaginitis\nDiaper Rash\nALT, AST elevated\nRenal Impairment\nAnemia",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Angioedema",
          "url": "https://wikem.org/wiki/Angioedema"
        },
        {
          "text": "Toxic epidermal necrolysis",
          "url": "https://wikem.org/wiki/TEN"
        },
        {
          "text": "Stevens-Johnson syndrome",
          "url": "https://wikem.org/wiki/Stevens-Johnson_Syndrome"
        },
        {
          "text": "Thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Seizures",
          "url": "https://wikem.org/wiki/Seizures"
        },
        {
          "text": "Clostridium difficile",
          "url": "https://wikem.org/wiki/Clostridium_difficile"
        },
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        },
        {
          "text": "Vaginitis",
          "url": "https://wikem.org/wiki/Vaginitis"
        }
      ]
    },
    "Common": {
      "text": "Diarrhea\nNausea/Vomiting\nJarisch-Herxheimer reaction\nVaginitis\nDiaper Rash\nALT, AST elevated\nRenal Impairment\nAnemia",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        },
        {
          "text": "Vaginitis",
          "url": "https://wikem.org/wiki/Vaginitis"
        }
      ]
    },
    "Pharmacology": {
      "text": "Half-life: 1.4 hours, 3.5 hours (CrCl 35),\nMetabolism: Minimal; CYP 450: unknown\nExcretion: Urinary primarily (Up to 100% unchanged)\nMechanism of Action: Bactericidal; inhibits cell wall mucopeptide synthesis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Antibiotic_Sensitivities": {
      "text": "",
      "subsections": {
        "Key": {
          "text": "S\nsusceptible/sensitive (usually)\nI\nintermediate (variably susceptible/resistant)\nR\nresistant (or not effective clinically)\nS+\nsynergistic with cell wall antibiotics\nU\nsensitive for UTI only (non systemic infection)\nX1\nno data\nX2\nactive in vitro, but not used clinically\nX3\nactive in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis\nX4\nactive in vitro, but not clinically effective for strep pneumonia",
          "tables": []
        }
      },
      "tables": [
        [
          {
            "Group": "Gram Positive",
            "Organism": "Strep. Group A, B, C, G",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Strep. Pneumoniae",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Viridans strep",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Strep. anginosus gp",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Enterococcus faecalis",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Enterococcus faecium",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "MSSA",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "MRSA",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "CA-MRSA",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Staph. Epidermidis",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "C. jeikeium",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "L. monocytogenes",
            "Sensitivity": "R"
          },
          {
            "Group": "Gram Negatives",
            "Organism": "N. gonorrhoeae",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "N. meningitidis",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Moraxella catarrhalis",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "H. influenzae",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "E. coli",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Klebsiellasp",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "E. coli/Klebsiella ESBL+",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "E coli/Klebsiella KPC+",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Enterobactersp, AmpC neg",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "Enterobactersp, AmpC pos",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Serratiasp",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Serratia marcescens",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Salmonellasp",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Shigellasp",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Proteus mirabilis",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Proteus vulgaris",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Providencia sp.",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Morganella sp.",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "Citrobacter freundii",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Citrobacter diversus",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "Citrobacter sp.",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "Aeromonas sp",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Acinetobacter sp.",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Pseudomonas aeruginosa",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Burkholderia cepacia",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Stenotrophomonas maltophilia",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Yersinia enterocolitica",
            "Sensitivity": "I"
          },
          {
            "Group": "",
            "Organism": "Francisella tularensis",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Brucella sp.",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Legionella sp.",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Pasteurella multocida",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Haemophilus ducreyi",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Vibrio vulnificus",
            "Sensitivity": "X1"
          },
          {
            "Group": "Misc",
            "Organism": "Chlamydophila sp",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Mycoplasm pneumoniae",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Rickettsia sp",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Mycobacterium avium",
            "Sensitivity": "X1"
          },
          {
            "Group": "Anaerobes",
            "Organism": "Actinomyces",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Bacteroides fragilis",
            "Sensitivity": "R"
          },
          {
            "Group": "",
            "Organism": "Prevotella melaninogenica",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Clostridium difficile",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Clostridium (not difficile)",
            "Sensitivity": "S"
          },
          {
            "Group": "",
            "Organism": "Fusobacterium necrophorum",
            "Sensitivity": "X1"
          },
          {
            "Group": "",
            "Organism": "Peptostreptococcus sp.",
            "Sensitivity": "S"
          }
        ]
      ],
      "links": []
    },
    "Key": {
      "text": "S\nsusceptible/sensitive (usually)\nI\nintermediate (variably susceptible/resistant)\nR\nresistant (or not effective clinically)\nS+\nsynergistic with cell wall antibiotics\nU\nsensitive for UTI only (non systemic infection)\nX1\nno data\nX2\nactive in vitro, but not used clinically\nX3\nactive in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis\nX4\nactive in vitro, but not clinically effective for strep pneumonia",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Antibiotics (Main)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antibiotics (Main)",
          "url": "https://wikem.org/wiki/Antibiotics_(Main)"
        }
      ]
    }
  }
}